e-learning
resources
Virtual 2021
07.09.2021
COVID-19 and management of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: Three case studies.
C. Bickert (Munich, Germany), K. Kahnert (Munich, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Götschke (Munich, Germany), Z. Syunyaeva (Munich, Germany), J. Behr (Munich, Germany), A. Tufman (Munich, Germany)
Source:
Virtual Congress 2021 – COVID-19 and management of lung cancer
Session:
COVID-19 and management of lung cancer
Session type:
E-poster
Number:
3859
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Bickert (Munich, Germany), K. Kahnert (Munich, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Götschke (Munich, Germany), Z. Syunyaeva (Munich, Germany), J. Behr (Munich, Germany), A. Tufman (Munich, Germany). Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: Three case studies.. 3859
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Consort hypersensitivity pneumonitis
Source: Eur Respir J 2009; 33: 1223-1225
Year: 2009
Effect of genotype on hypersensitivity pneumonitis despite treatment.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Clinical course in hypersensitivity pneumonitis: a review of 38 cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Characterisation of patients with chronic hypersensitivity pneumonitis (CHP) - a seven year single centre experience
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Iloprost-induced thrombocytopenia: a case proven by rechallenge
Source: Eur Respir J 2010; 36: 967-969
Year: 2010
Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006
Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
Can persulfates cause hypersensitivity pneumonitis? A report of specific inhalation challenge test in 42 hairdressers
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020
Rituximab-induced lung disease: a systematic literature review
Source: Eur Respir J 2010; 35: 681-687
Year: 2010
Gemcitabine induced pulmonary toxicity in a single patient: case report
Source: Eur Respir J 2006; 28: Suppl. 50, 753s
Year: 2006
Hypersensitivity pneumonitis associated with the use of temozolomide
Source: Eur Respir J 2009; 33: 931-934
Year: 2009
Pigeon breeder‘s hypersensitivity pneumonitis – possible antigen exposure reduction after diagnosis in the most susceptible patients
Source: Annual Congress 2009 - High molecular sensitisers and biological dusts
Year: 2009
Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019
Standard therapy for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005
Tuberculosis therapy: past, present and future
Source: Eur Respir J 2002; 20: 87S-94S
Year: 2002
Community-aquired pneumonia: systemic and local inflammatory response in treatment failure
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept